BI
BVF Inc’s Cullinan Oncology CGEM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.3M | Hold |
5,750,683
| – | – | 1.55% | 14 |
|
|
2025
Q1 | $43.5M | Hold |
5,750,683
| – | – | 1.77% | 12 |
|
|
2024
Q4 | $70M | Hold |
5,750,683
| – | – | 2.37% | 9 |
|
|
2024
Q3 | $96.3M | Hold |
5,750,683
| – | – | 2.82% | 8 |
|
|
2024
Q2 | $100M | Buy |
5,750,683
+2,553,982
| +80% | +$44.5M | 2.81% | 8 |
|
|
2024
Q1 | $54.5M | Hold |
3,196,701
| – | – | 1.5% | 18 |
|
|
2023
Q4 | $32.6M | Hold |
3,196,701
| – | – | 0.82% | 30 |
|
|
2023
Q3 | $28.9M | Hold |
3,196,701
| – | – | 0.78% | 27 |
|
|
2023
Q2 | $34.4M | Hold |
3,196,701
| – | – | 0.96% | 29 |
|
|
2023
Q1 | $32.7M | Sell |
3,196,701
-4,312,358
| -57% | -$44.1M | 1.2% | 28 |
|
|
2022
Q4 | $79.2M | Hold |
7,509,059
| – | – | 3.34% | 7 |
|
|
2022
Q3 | $96.3M | Hold |
7,509,059
| – | – | 3.98% | 7 |
|
|
2022
Q2 | $96.3M | Buy |
7,509,059
+2,139,600
| +40% | +$27.4M | 4.65% | 4 |
|
|
2022
Q1 | $56.2M | Hold |
5,369,459
| – | – | 2.25% | 13 |
|
|
2021
Q4 | $82.9M | Buy |
5,369,459
+4,634,353
| +630% | +$71.5M | 3.01% | 10 |
|
|
2021
Q3 | $16.6M | Hold |
735,106
| – | – | 0.65% | 41 |
|
|
2021
Q2 | $18.9M | Sell |
735,106
-314,250
| -30% | -$8.09M | 0.71% | 38 |
|
|
2021
Q1 | $43.7M | Buy |
+1,049,356
| New | +$43.7M | 1.64% | 21 |
|